Trial Profile
Pilot Trial of Hemodialysis Patient Aldosterone antagoniSm With Eplerenone Trial
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary)
- Indications Heart failure; Hypertension
- Focus Adverse reactions
- Acronyms PHASE; PHASE1
- 19 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Nov 2013 Planned end date changed from 1 Oct 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 15 May 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.